The latest edition of Clinics in Plastic Surgery just released. Link to download the VENOUS MALFORMATION chapter by Dr Julien Coulie from our Vascular Anomaly Centre for free until 25/8/2026. Enjoy reading it. #VASCAPA #CMTC #HEVAS #VASCERN #ISSVA
authors.elsevier.com/a/1nOYuLPnEr...
authors.elsevier.com/a/1nOYuLPnEr...
July 8, 2026 at 9:08 AM
Exciting #ISSVA 2026. 100 presentations, posters, intense discussions and sponsored sessions. A great keynote by Taija Makinen. A touching tribute to the late founder, John Mulliken, underscoring curiosity, accuracy and collaboration. ISSVA Dublin 5-7 May 2027.
#VASCERN -VASCA #VASCAPA #HEVAS #CMTC
#VASCERN -VASCA #VASCAPA #HEVAS #CMTC
May 22, 2026 at 2:46 PM
🟢 #$PVLA — Clinical Readout
New SELVA Phase 3 Data Presented at ISSVA 2026 - QTORIN Rapamycin for Microcystic Lymphatic Malformations
Additional data from the Phase 3 SELVA study of QTORIN rapamycin presented at the ISSVA World Congress 2026. In participants ag…
https://biostock.app/symbols/PVLA
New SELVA Phase 3 Data Presented at ISSVA 2026 - QTORIN Rapamycin for Microcystic Lymphatic Malformations
Additional data from the Phase 3 SELVA study of QTORIN rapamycin presented at the ISSVA World Congress 2026. In participants ag…
https://biostock.app/symbols/PVLA
May 20, 2026 at 8:42 PM
🟢 #$PVLA — Clinical Readout
New SELVA Phase 3 Data Presented at ISSVA 2026 - QTORIN Rapamycin for Microcystic Lymphatic Malformations
Additional data from the Phase 3 SELVA study of QTORIN rapamycin presented at the ISSVA World Congress 2026. In participants ag…
https://biostock.app/symbols/PVLA
New SELVA Phase 3 Data Presented at ISSVA 2026 - QTORIN Rapamycin for Microcystic Lymphatic Malformations
Additional data from the Phase 3 SELVA study of QTORIN rapamycin presented at the ISSVA World Congress 2026. In participants ag…
https://biostock.app/symbols/PVLA
#ISSVA 2026 has started. Great to meet again friends and colleagues to discuss #vascular #anomalies. #vascapa #hevas #cmtc #deduveinstitute #Vascern
May 19, 2026 at 11:50 PM
#ISSVA 2026 has started. Great to meet again friends and colleagues to discuss #vascular #anomalies. #vascapa #hevas #cmtc #deduveinstitute #Vascern
🟢 #$RLAY — Clinical Readout
Phase 2 ReInspire Trial Initial Data - Zovegalisib in PIK3CA-Driven Vascular Anomalies (60% VRR at ISSVA 2026)
Initial data from Phase 2 ReInspire trial of zovegalisib in PIK3CA-driven vascular anomalies presented at ISSVA World Cong…
https://biostock.app/symbols/RLAY
Phase 2 ReInspire Trial Initial Data - Zovegalisib in PIK3CA-Driven Vascular Anomalies (60% VRR at ISSVA 2026)
Initial data from Phase 2 ReInspire trial of zovegalisib in PIK3CA-driven vascular anomalies presented at ISSVA World Cong…
https://biostock.app/symbols/RLAY
May 19, 2026 at 12:52 PM
🟢 #$RLAY — Clinical Readout
Phase 2 ReInspire Trial Initial Data - Zovegalisib in PIK3CA-Driven Vascular Anomalies (60% VRR at ISSVA 2026)
Initial data from Phase 2 ReInspire trial of zovegalisib in PIK3CA-driven vascular anomalies presented at ISSVA World Cong…
https://biostock.app/symbols/RLAY
Phase 2 ReInspire Trial Initial Data - Zovegalisib in PIK3CA-Driven Vascular Anomalies (60% VRR at ISSVA 2026)
Initial data from Phase 2 ReInspire trial of zovegalisib in PIK3CA-driven vascular anomalies presented at ISSVA World Cong…
https://biostock.app/symbols/RLAY
Exciting 1st day at #iDR26 on #drug #repurposing. Academics, companies, funders, policymakers & patients, gathered to discuss how to #repurpose #medicines for #diseases with unmet medical needs, incl. #vascular anomalies. #VASCERN #VASCAPA #HEVAS #CMTC #Eurordis #WELRI #deDuveInstitute #FNRS #ISSVA
May 12, 2026 at 2:48 PM
Exciting 1st day at #iDR26 on #drug #repurposing. Academics, companies, funders, policymakers & patients, gathered to discuss how to #repurpose #medicines for #diseases with unmet medical needs, incl. #vascular anomalies. #VASCERN #VASCAPA #HEVAS #CMTC #Eurordis #WELRI #deDuveInstitute #FNRS #ISSVA
Fabian’s great work: Volumetric perfusion fraction change in MR angiography for monitoring sclerotherapy-related changes in peripheral #venous #malformations published. Free access until 13/6/2026: authors.elsevier.com/c/1m~tx,GNpk...
#VASCERN #VASCAPA #HEVAS #CMTC #Welbio #deDuveInstitute #ISSVA
#VASCERN #VASCAPA #HEVAS #CMTC #Welbio #deDuveInstitute #ISSVA
April 28, 2026 at 1:53 PM
Fabian’s great work: Volumetric perfusion fraction change in MR angiography for monitoring sclerotherapy-related changes in peripheral #venous #malformations published. Free access until 13/6/2026: authors.elsevier.com/c/1m~tx,GNpk...
#VASCERN #VASCAPA #HEVAS #CMTC #Welbio #deDuveInstitute #ISSVA
#VASCERN #VASCAPA #HEVAS #CMTC #Welbio #deDuveInstitute #ISSVA
Congratulations Emmanuel on showing how #sirolimus treatment can be adapted. #patients with #slow-#flow #vascular #malformations have #symptom reduction even with #intermittent dosing. A big step forward in the #multimodal management of VAs. #VASCERN #VASCAPA #CMTC #HEVAS #ISSVA #EVDays #Lymph
December 17, 2025 at 7:25 AM
Congratulations Emmanuel on showing how #sirolimus treatment can be adapted. #patients with #slow-#flow #vascular #malformations have #symptom reduction even with #intermittent dosing. A big step forward in the #multimodal management of VAs. #VASCERN #VASCAPA #CMTC #HEVAS #ISSVA #EVDays #Lymph
The virtual #European #Angiology Days (EADays) 2025 are just over. Great presentations and discussions. And easy access - no travel !! Stay tuned for the #EADays – VAS-INT 2026 meeting, which will take place virtually from 27 to 29 November, 2026. #VASCERN #VASCAPA #HEVAS #CMTC #ISSVA #NAVBO #EVBO
December 15, 2025 at 1:41 PM
If you are interested in the clinical aspects of lymphatic diseases, don't miss the 30th ISL World Congress of Lymphology. #lymph @vascern.bsky.social
#issva #theralymph
#issva #theralymph
May 9, 2025 at 12:00 PM
If you are interested in the clinical aspects of lymphatic diseases, don't miss the 30th ISL World Congress of Lymphology. #lymph @vascern.bsky.social
#issva #theralymph
#issva #theralymph
The great #ISSVA debates meeting 2025 meeting has come to an end. Nothing compares to F2F discussions and networking. Looking forward to the ISSVA World Congress 2026 in #Philadelphia #vascapa #hevas #CMTC #VASCERN #LE&RN #ESL #ISL #vascular #lymphatic #syndrome #hemangioma #theranostic #repurposing
April 26, 2025 at 11:00 AM
The great #ISSVA debates meeting 2025 meeting has come to an end. Nothing compares to F2F discussions and networking. Looking forward to the ISSVA World Congress 2026 in #Philadelphia #vascapa #hevas #CMTC #VASCERN #LE&RN #ESL #ISL #vascular #lymphatic #syndrome #hemangioma #theranostic #repurposing
I hope these pathways will help both junior and senior physicians to manage these patients , and to those affected by these vascular diseases to obtain faster a definite diagnosis. #vascapa #vascern #cmtc #hevas #vascern #capillary #malformation #evbo #navbo #issva #leducq #theralymph
March 5, 2025 at 7:13 AM
I hope these pathways will help both junior and senior physicians to manage these patients , and to those affected by these vascular diseases to obtain faster a definite diagnosis. #vascapa #vascern #cmtc #hevas #vascern #capillary #malformation #evbo #navbo #issva #leducq #theralymph
Three other interesting meetings in 2025 in Europe on vascular anomalies and lymphedema: #ISSVA debates and Updates,Paris (www.issva.org/2025); 1st European #Lymphatic Symposium,Toulouse (european-lymphatic-symposium.com), and the ISL World Congress of Lymphology, Antalya(www.isl2025lymphology.org).
February 20, 2025 at 11:15 AM
Three other interesting meetings in 2025 in Europe on vascular anomalies and lymphedema: #ISSVA debates and Updates,Paris (www.issva.org/2025); 1st European #Lymphatic Symposium,Toulouse (european-lymphatic-symposium.com), and the ISL World Congress of Lymphology, Antalya(www.isl2025lymphology.org).
Three other interesting meetings in 2025 in Europe on vascular anomalies and lymphedema: #ISSVA debates and Updates,Paris (www.issva.org/2025); 1st European #Lymphatic Symposium,Toulouse (european-lymphatic-symposium.com), & the ISL World Congress of Lymphology,Antalya (www.isl2025lymphology.org).
February 20, 2025 at 11:13 AM
Three other interesting meetings in 2025 in Europe on vascular anomalies and lymphedema: #ISSVA debates and Updates,Paris (www.issva.org/2025); 1st European #Lymphatic Symposium,Toulouse (european-lymphatic-symposium.com), & the ISL World Congress of Lymphology,Antalya (www.isl2025lymphology.org).
Today VASCA@Berlin… next: ISSVA@Paris www.issva.org/2025
ISSVA Debates & Updates 2025 | ISSVA DEBATES & UPDATES 2025
www.issva.org
February 10, 2025 at 9:47 PM
Today VASCA@Berlin… next: ISSVA@Paris www.issva.org/2025
International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! : lnkd.in/e6_BbzQF. Don't miss the event. The congress networking dinner nearly sold out! A few seats left for congress participation. lnkd.in/dzTfFVej
#VASCAPA #HEVAS #CMTC #EVBO #ISSVA
#VASCAPA #HEVAS #CMTC #EVBO #ISSVA
February 6, 2025 at 5:23 PM
International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! : lnkd.in/e6_BbzQF. Don't miss the event. The congress networking dinner nearly sold out! A few seats left for congress participation. lnkd.in/dzTfFVej
#VASCAPA #HEVAS #CMTC #EVBO #ISSVA
#VASCAPA #HEVAS #CMTC #EVBO #ISSVA
4 days left before we the International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! Exciting program on novel preclinical models, drugs and results from clinical trials! lnkd.in/e6_BbzQF. Register at: lnkd.in/dzTfFVej #VASCAPA #HEVAS #CMTC #EVBO #ISSVA
February 6, 2025 at 5:20 PM
4 days left before we the International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! Exciting program on novel preclinical models, drugs and results from clinical trials! lnkd.in/e6_BbzQF. Register at: lnkd.in/dzTfFVej #VASCAPA #HEVAS #CMTC #EVBO #ISSVA
International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! : Exciting program, including novel preclinical models, drugs, and most recent results from clinical trials! lnkd.in/e6_BbzQF. Registrations: lnkd.in/dzTfFVej
#VASCAPA #HEVAS #CMTC #EVBO #ISSVA
#VASCAPA #HEVAS #CMTC #EVBO #ISSVA
January 23, 2025 at 4:07 PM
International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! : Exciting program, including novel preclinical models, drugs, and most recent results from clinical trials! lnkd.in/e6_BbzQF. Registrations: lnkd.in/dzTfFVej
#VASCAPA #HEVAS #CMTC #EVBO #ISSVA
#VASCAPA #HEVAS #CMTC #EVBO #ISSVA